During the past decade, International Clinical Research - US, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Clinical Research - US, LLC" #1 sponsor was "Dermira, Inc." with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Actavis Inc." with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Clinical Research - US, LLC" #1 collaborator was "Covance" with 1 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "International Clinical Research - US, LLC" are "Acne Vulgaris" (4 trials), "Atopic Dermatitis" (3 trials), "Crohn's Disease" (2 trials), "Chronic Low Back Pain" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "International Clinical Research - US, LLC" in a lesser frequency.

Most popular intervention types in "International Clinical Research - US, LLC" are "Drug" (21 trials), "Biological" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vehicle" (4 trials), "placebo" (3 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "Anrukinzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Clinical Research - US, LLC" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "International Clinical Research - US, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in International Clinical Research - US, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in International Clinical Research - US, LLC, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".